These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9796441

  • 21. Comparison of the in vivo photodynamic threshold dose for photofrin, mono- and tetrasulfonated aluminum phthalocyanine using a rat liver model.
    Farrell TJ, Wilson BC, Patterson MS, Olivo MC.
    Photochem Photobiol; 1998 Sep; 68(3):394-9. PubMed ID: 9747595
    [Abstract] [Full Text] [Related]

  • 22. Time-dependent biodistribution of tetra(m-hydroxyphenyl)chlorin and benzoporphyrin derivative monoacid ring A in the hamster model: comparative fluorescence microscopy study.
    Andrejevic Blant S, Ballini JP, van den Bergh H, Fontolliet C, Wagnières G, Monnier P.
    Photochem Photobiol; 2000 Mar; 71(3):333-40. PubMed ID: 10732452
    [Abstract] [Full Text] [Related]

  • 23. High efficiency of benzoporphyrin derivative in the photodynamic therapy of pigmented malignant melanoma.
    Busetti A, Soncin M, Jori G, Rodgers MA.
    Br J Cancer; 1999 Feb; 79(5-6):821-4. PubMed ID: 10070875
    [Abstract] [Full Text] [Related]

  • 24. Improved pharmacokinetics, biodistribution and necrosis in vivo using a new near infra-red photosensitizer: tetrahydroporphyrin tetratosylat.
    Schastak S, Jean B, Handzel R, Kostenich G, Hermann R, Sack U, Orenstein A, Wang YS, Wiedemann P.
    J Photochem Photobiol B; 2005 Mar 01; 78(3):203-13. PubMed ID: 15708517
    [Abstract] [Full Text] [Related]

  • 25. Photodynamic therapy targeted to tumor-induced angiogenic vessels.
    Kurohane K, Tominaga A, Sato K, North JR, Namba Y, Oku N.
    Cancer Lett; 2001 Jun 10; 167(1):49-56. PubMed ID: 11323098
    [Abstract] [Full Text] [Related]

  • 26. Selective depletion of a thymocyte subset in vitro with an immunomodulatory photosensitizer.
    Jiang H, Granville DJ, McManus BM, Levy JG, Hunt DW.
    Clin Immunol; 1999 May 10; 91(2):178-87. PubMed ID: 10227810
    [Abstract] [Full Text] [Related]

  • 27. Simple, reliable and fast spectrofluorometric method for determination of plasma Verteporfin (Visudyne) levels during photodynamic therapy for choroidal neovascularization.
    Aquaron R, Forzano O, Murati JL, Fayet G, Aquaron C, Ridings B.
    Cell Mol Biol (Noisy-le-grand); 2002 Dec 10; 48(8):925-30. PubMed ID: 12699252
    [Abstract] [Full Text] [Related]

  • 28. Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.
    Weston MA, Patterson MS.
    Photochem Photobiol; 2011 Dec 10; 87(5):1129-37. PubMed ID: 21575000
    [Abstract] [Full Text] [Related]

  • 29. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA, Gollnick SO, Camacho SH, Greco WR, Cheney RT.
    Cancer Res; 2003 Nov 15; 63(22):7584-90. PubMed ID: 14633671
    [Abstract] [Full Text] [Related]

  • 30. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent.
    Henderson BW, Sitnik-Busch TM, Vaughan LA.
    Photochem Photobiol; 1999 Jul 15; 70(1):64-71. PubMed ID: 10420844
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
    Chan AL, Juarez M, Allen R, Volz W, Albertson T.
    Photodermatol Photoimmunol Photomed; 2005 Apr 15; 21(2):72-8. PubMed ID: 15752124
    [Abstract] [Full Text] [Related]

  • 32. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
    Maugain E, Sasnouski S, Zorin V, Merlin JL, Guillemin F, Bezdetnaya L.
    Oncol Rep; 2004 Sep 15; 12(3):639-45. PubMed ID: 15289849
    [Abstract] [Full Text] [Related]

  • 33. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.
    Buchholz J, Kaser-Hotz B, Khan T, Rohrer Bley C, Melzer K, Schwendener RA, Roos M, Walt H.
    Clin Cancer Res; 2005 Oct 15; 11(20):7538-44. PubMed ID: 16243829
    [Abstract] [Full Text] [Related]

  • 34. In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model.
    Iinuma S, Schomacker KT, Wagnieres G, Rajadhyaksha M, Bamberg M, Momma T, Hasan T.
    Cancer Res; 1999 Dec 15; 59(24):6164-70. PubMed ID: 10626808
    [Abstract] [Full Text] [Related]

  • 35. Tissue distribution and in vivo photosensitizing activity of 13,15-[N-(3-hydroxypropyl)]cycloimide chlorin p6 and 13,15-(N-methoxy)cycloimide chlorin p6 methyl ester.
    Karmakova T, Feofanov A, Pankratov A, Kazachkina N, Nazarova A, Yakubovskaya R, Lebedeva V, Ruziyev R, Mironov A, Maurizot JC, Vigny P.
    J Photochem Photobiol B; 2006 Jan 02; 82(1):28-36. PubMed ID: 16236520
    [Abstract] [Full Text] [Related]

  • 36. Distribution of photosensitizers in bladder cancer spheroids: implications for intravesical instillation of photosensitizers for photodynamic therapy of bladder cancer.
    Xiao Z, Hansen CB, Allen TM, Miller GG, Moore RB.
    J Pharm Pharm Sci; 2005 Sep 28; 8(3):536-43. PubMed ID: 16401399
    [Abstract] [Full Text] [Related]

  • 37. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy.
    Bovis MJ, Woodhams JH, Loizidou M, Scheglmann D, Bown SG, Macrobert AJ.
    J Control Release; 2012 Jan 30; 157(2):196-205. PubMed ID: 21982898
    [Abstract] [Full Text] [Related]

  • 38. An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy.
    Henderson BW, Bellnier DA, Greco WR, Sharma A, Pandey RK, Vaughan LA, Weishaupt KR, Dougherty TJ.
    Cancer Res; 1997 Sep 15; 57(18):4000-7. PubMed ID: 9307285
    [Abstract] [Full Text] [Related]

  • 39. Choice of optimal wavelength for PDT: the significance of oxygen depletion.
    Nielsen KP, Juzeniene A, Juzenas P, Stamnes K, Stamnes JJ, Moan J.
    Photochem Photobiol; 2005 Sep 15; 81(5):1190-4. PubMed ID: 15934793
    [Abstract] [Full Text] [Related]

  • 40. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
    Du HY, Bay BH, Olivo M.
    Int J Oncol; 2003 May 15; 22(5):1019-24. PubMed ID: 12684667
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.